Cargando…
The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review
BACKGROUND: The World Health Organization estimates that diabetes is the seventh leading cause of death. Uncontrolled diabetes may cause severe consequences such as cardiovascular (CV) events (myocardial infarction, stroke, or CV mortality), lower-extremity amputations, and end-stage renal disease....
Autores principales: | Taylor, Olesya M., Lam, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424199/ https://www.ncbi.nlm.nih.gov/pubmed/32817765 http://dx.doi.org/10.1016/j.curtheres.2020.100596 |
Ejemplares similares
-
Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016) -
Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
por: Dave, Darshan J.
Publicado: (2011) -
Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
por: Esaki, Hiroki, et al.
Publicado: (2017) -
Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
por: Nishida, Yayoi, et al.
Publicado: (2020) -
Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)